Why did HealthStream (HSTM) stock move recently?

On 7/22/2026, HealthStream moved -3.4% — HealthStream shares fell with the broader market or sector amid no company-specific news or filings today. This is MarketChacha's decoded reason from filings and credible news; it is education, not buy/sell advice.

Is HealthStream (HSTM) overvalued or fairly valued?

MarketChacha shows HealthStream's valuation in context — a trailing P/E of about 41.6, a forward P/E of about 38.3, a price-to-book of about 2.8 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does HealthStream's reported profit turn into cash?

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (3.45×) from reported figures — education, not a rating.

What is HealthStream's revenue?

HealthStream reported revenue of $304.1M for FY2025, with net profit of $18.3M, per official filings.

What is the share price of HealthStream (HSTM)?

HealthStream last traded at $33.69 (+1.1% on the day), as of 10/20/2026 — a delayed quote shown for education, not investment advice.

HealthStream

HSTM · NYSE · Healthcare · United States

Snapshot

TickerHSTM

ExchangeNYSE

SectorHealthcare

IndustryHealth Information Services

CountryUnited States

Employees1,139

HeadquartersNashville, United States

Websitewww.healthstream.com

Filings tracked18

About HealthStream

HealthStream, Inc. provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company offers hStream, a technology platform; CredentialStream, provides healthcare organizations with tools to support the provider lifecycle management from recruiting, application submission, verification of licensure and other credentials, privileging, appointments by credentialing committees, enrollment, network, management, onboarding, and performance evaluations of providers; ShiftWizard; and Competency Suite, AI/ML-driven clinical competency development system. It also provides applications for performance appraisal, competency management, disclosure management, clinical competency, assessment, development, simulation-based education, clinical rotation and onboarding management, quality management, and industry training. The company's solutions help healthcare organizations in meeting their ongoing learning, clinical development, credentialing, and scheduling needs. It serves the healthcare industry, including private, not-for-profit, and government entities, as well as pharmaceutical and medical device companies, and nursing schools and students. The company was incorporated in 1990 and is headquartered in Nashville, Tennessee.

Who owns it

Insiders29.5%
Institutions70.5%
Public & other0.0%

311 institutional holders

Ownership breakdown from public market data.

Top holders

Blackrock Inc.13.97%
Dimensional Fund Advisors LP5.33%
Copeland Capital Management, LLC4.17%
Vanguard Capital Management LLC3.58%
State Street Corporation3.44%
Vanguard Portfolio Management LLC3.01%
Two Sigma Investments, LP2.76%
Geode Capital Management, LLC2.67%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

Latest ROE of 5.2% is on the low side — the business earns a modest return on shareholder capital.

Cash conversion3.45×

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend5.5% → 6.0%

Margin has held broadly steady over the period — stable profitability.

Return on equity5.2%

Latest ROE of 5.2% is on the low side — the business earns a modest return on shareholder capital.

Growth qualityrev 4% · PAT 10%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $82.9M · EPS 0.15

Est. earnings growth -16.7%

Next fiscal year

Rev $344.6M · EPS 0.89

Est. earnings growth +21.2%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2025)

$304.1M

Net margin

6.0%

ROE

5.2%

Revenue CAGR (2y)

+4.4%

Profit CAGR (2y)

+9.8%

EPS (FY2025)

0.61

Net profit (FY2025)

$18.3M

Ask MarketChacha about HSTM

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

Jul 22, 2026
HealthStream shares fell with the broader market or sector amid no company-specific news or filings today.
· confidence: low

Daily moves with the verified reason behind them. Education only — not investment advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$304.1M	$18.3M	0.61	6.0%	5.2%
FY2024	$291.6M	$20.0M	0.66	6.9%	5.6%
FY2023	$279.1M	$15.2M	0.50	5.5%	4.5%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q2	$83.7M	$6.7M	0.23	8.0%
2026Q1	$81.2M	$5.9M	0.20	7.3%
2025Q3	$76.5M	$6.1M	0.20	8.0%
2025Q2	$74.4M	$5.4M	0.18	7.2%
2025Q1	$73.5M	$4.3M	0.14	5.9%
2024Q3	$73.1M	$5.7M	0.19	7.8%
2024Q2	$71.6M	$4.2M	0.14	5.8%
2024Q1	$72.8M	$5.2M	0.17	7.2%
2023Q3	$70.3M	$3.9M	0.13	5.5%
2023Q2	$69.2M	$4.1M	0.13	6.0%
2023Q1	$68.9M	$2.6M	0.09	3.8%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

10-Q — FORM 10-Q
SEC8/6/2026
8-K — Results of operations, Reg FD disclosure, Other events, Exhibits
SEC8/3/2026material
8-K — Other events
SEC7/29/2026material
8-K — Shareholder vote results, Exhibits
SEC5/29/2026material
8-K — Executive/director change
SEC5/8/2026material
10-Q — FORM 10-Q
SEC5/6/2026
8-K — Results of operations, Reg FD disclosure, Other events, Exhibits
SEC5/4/2026material
8-K — Material agreement, Other events, Exhibits
SEC3/13/2026material
10-K — FORM 10-K
SEC2/27/2026
8-K — Results of operations, Reg FD disclosure, Other events, Exhibits
SEC2/23/2026material

2025

8-K — Other events, Exhibits
SEC12/15/2025material
8-K — Other events, Exhibits
SEC12/9/2025material
8-K — Other events, Exhibits
SEC11/12/2025material
10-Q — FORM 10-Q
SEC11/6/2025
8-K — Results of operations, Reg FD disclosure, Other events, Exhibits
SEC11/3/2025material
8-K — Other events, Exhibits
SEC10/9/2025material
10-Q — FORM 10-Q
SEC8/7/2025
8-K — Results of operations, Reg FD disclosure, Other events, Exhibits
SEC8/4/2025material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.